Pacira gets FDA blessing for pain drug; Japan approves Parabolic's API production;

@FiercePharma:  Momenta wins injunction against rival Lovenox copy, thwarting Amphastar/Watson.  News | Follow @FiercePharma

> Pacira Pharmaceuticals won the FDA nod for its post-surgical pain drug Exparel. Release

> Nephron Pharmaceuticals plans a $313 million plant in South Carolina, aiming to add more than 700 jobs as the facility ramps up. News

> Indian API maker Parabolic Drugs won official accreditation from Japan's health regulators, allowing it to supply antibiotic products to Japanese drugmakers. Article

> U.K. proposals to allow pharmacists to alter prescriptions without consulting the prescriber are coming under some criticism. Item

> A fire at a Pfizer ($PFE) animal health research facility damaged several buildings and destroyed one hay barn. News

> Indian drugmakers worry that new pricing regulations on essential meds will favor foreign pharma companies. Report

> An Australian woman sued Merck's ($MRK) domestic unit, alleging that a Gardasil injection triggered her neurological problems. Story

> Vertex Pharmaceuticals ($VRTX) got three new price targets from analysts, with UBS assigning a $47 target, Piper Jaffray picking $63, and JMP Securities coming in between with $53. News

Biotech News

@FierceBiotech: Slideshow: 10 mobile apps in Life Sciences. Report | Follow @FierceBiotech

@JohnCFierce: Thanks to Bayer, Novo Nordisk, Glaxo, Spinifex and Imperial college for participating on academic/biotech panel at BioEurope. | Follow @JohnCFierce

@RyanMFierce: Obama steps up action on drug shortages with FDA mandate. News | Follow @RyanMFierce

@MaureenFierce: Happy Halloween! Check out our 2011 Biotech Graveyard report. Report | Follow @MaureenFierce

> Pacira stock surges after FDA nod for post-surgery pain drug Exparel. News

> VC drought for biotech hits hard in Europe with 44% drop in 3Q investment. Article

Biotech IT News

> Suspected anti-Parkinson's gene spotted in 23andMe database. Story

> PLoS tackles bioinformatics for beginners. News

> J&J links up with Foundation Medicine for cancer genomic test. Article

> McGill U. teams with eVision to speed clinical trial starts. News

> TrialReach rounds up $1.2M for online trial recruitment. Item

Medical Device News

> Stratatech gets $4.6M for skin substitute trial. News

> BD debuts AutoShield Duo. Story

> FDA OKs Gen-Probe HPV test. Report

> Occlutech scores another win against St Jude-AGA Medical. Item

> FDA OKs Medtronic study for Type 1 diabetes management. Article

> FDA panel gives AtriCure good news on Synergy system. Story

And Finally... Brain activity during dreams matches activity associated with similar movements in real life, a study found. Article

Suggested Articles

Saturday, AstraZeneca revealed more of the data that convinced the FDA to green-light Calquence in previously untreated chronic lymphocytic leukemia.

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.